(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 55.71% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.46%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.77%.
Electrocore's revenue in 2023 is $8,592,000.On average, 2 Wall Street analysts forecast ECOR's revenue for 2023 to be $69,073,784, with the lowest ECOR revenue forecast at $69,050,072, and the highest ECOR revenue forecast at $69,097,497. On average, 2 Wall Street analysts forecast ECOR's revenue for 2024 to be $108,839,228, with the lowest ECOR revenue forecast at $107,179,370, and the highest ECOR revenue forecast at $110,499,085.
In 2025, ECOR is forecast to generate $155,931,756 in revenue, with the lowest revenue forecast at $155,931,756 and the highest revenue forecast at $155,931,756.